首页> 美国卫生研究院文献>BMC Biochemistry >Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II
【2h】

Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II

机译:核膜联蛋白II负调控LNCaP细胞的生长并用ser 11和25取代glu阻止膜联蛋白II的核质穿梭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAnnexin II heavy chain (also called p36, calpactin I) is lost in prostate cancers and in a majority of prostate intraepithelial neoplasia (PIN). Loss of annexin II heavy chain appears to be specific for prostate cancer since overexpression of annexin II is observed in a majority of human cancers, including pancreatic cancer, breast cancer and brain tumors. Annexin II exists as a heterotetramer in complex with a protein ligand p11 (S100A10), and as a monomer. Diverse cellular functions are proposed for the two forms of annexin II. The monomer is involved in DNA synthesis. A leucine-rich nuclear export signal (NES) in the N-terminus of annexin II regulates its nuclear export by the CRM1-mediated nuclear export pathway. Mutation of the NES sequence results in nuclear retention of annexin II.
机译:背景Annexin II重链(也称为p36,钙蛋白酶I)在前列腺癌和大多数前列腺上皮内瘤变(PIN)中丢失。膜联蛋白II重链的丢失似乎对前列腺癌具有特异性,因为在大多数人类癌症(包括胰腺癌,乳腺癌和脑瘤)中观察到膜联蛋白II的过度表达。膜联蛋白II作为异四聚体与蛋白质配体p11(S100A10)复合存在,并作为单体存在。对于膜联蛋白II的两种形式,提出了多种细胞功能。该单体参与DNA合成。膜联蛋白II的N末端富含亮氨酸的核出口信号(NES)通过CRM1介导的核出口途径调节其核出口。 NES序列的突变导致膜联蛋白II的核保留。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号